330 related articles for article (PubMed ID: 31383654)
1. Resistance and Heteroresistance to Colistin in Pseudomonas aeruginosa Isolates from Wenzhou, China.
Lin J; Xu C; Fang R; Cao J; Zhang X; Zhao Y; Dong G; Sun Y; Zhou T
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31383654
[TBL] [Abstract][Full Text] [Related]
2. Mutations and expression of PmrAB and PhoPQ related with colistin resistance in Pseudomonas aeruginosa clinical isolates.
Lee JY; Ko KS
Diagn Microbiol Infect Dis; 2014 Mar; 78(3):271-6. PubMed ID: 24412662
[TBL] [Abstract][Full Text] [Related]
3. Resistance and Heteroresistance to Colistin in
Liao W; Lin J; Jia H; Zhou C; Zhang Y; Lin Y; Ye J; Cao J; Zhou T
Infect Drug Resist; 2020; 13():3551-3561. PubMed ID: 33116674
[TBL] [Abstract][Full Text] [Related]
4. Contribution of Novel Amino Acid Alterations in PmrA or PmrB to Colistin Resistance in
Sato T; Shiraishi T; Hiyama Y; Honda H; Shinagawa M; Usui M; Kuronuma K; Masumori N; Takahashi S; Tamura Y; Yokota SI
Antimicrob Agents Chemother; 2018 Sep; 62(9):. PubMed ID: 29914952
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and molecular characteristics of colistin-resistant isolates among clinically isolated carbapenem-resistant Klebsiella pneumoniae in China.
Hu H; Shi Q; Zhang P; Quan J; Han X; Zhao D; Zhang H; Wang Q; Jiang Y; Yu Y
Int J Antimicrob Agents; 2023 Aug; 62(2):106873. PubMed ID: 37276893
[TBL] [Abstract][Full Text] [Related]
6. Deciphering colistin heteroresistance in Acinetobacter baumannii clinical isolates from Wenzhou, China.
Chen L; Lin J; Lu H; Zhang X; Wang C; Liu H; Zhang X; Li J; Cao J; Zhou T
J Antibiot (Tokyo); 2020 Jul; 73(7):463-470. PubMed ID: 32152526
[TBL] [Abstract][Full Text] [Related]
7. Identification of nonclonal Pseudomonas aeruginosa isolates with reduced colistin susceptibility in Korea.
Lee JY; Song JH; Ko KS
Microb Drug Resist; 2011 Jun; 17(2):299-304. PubMed ID: 21381965
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and molecular characterization of colistin resistance in Pseudomonas aeruginosa isolates: insights from a study in Ardabil hospitals.
Jafari-Ramedani S; Nazari M; Arzanlou M; Peeri-Dogaheh H; Sahebkar A; Khademi F
BMC Microbiol; 2024 May; 24(1):152. PubMed ID: 38702660
[TBL] [Abstract][Full Text] [Related]
9. Aminoarabinosylation of Lipid A Is Critical for the Development of Colistin Resistance in Pseudomonas aeruginosa.
Lo Sciuto A; Imperi F
Antimicrob Agents Chemother; 2018 Mar; 62(3):. PubMed ID: 29263076
[TBL] [Abstract][Full Text] [Related]
10. PhoQ mutations promote lipid A modification and polymyxin resistance of Pseudomonas aeruginosa found in colistin-treated cystic fibrosis patients.
Miller AK; Brannon MK; Stevens L; Johansen HK; Selgrade SE; Miller SI; Høiby N; Moskowitz SM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5761-9. PubMed ID: 21968359
[TBL] [Abstract][Full Text] [Related]
11. The Efflux Pump MexXY/OprM Contributes to the Tolerance and Acquired Resistance of Pseudomonas aeruginosa to Colistin.
Puja H; Bolard A; Noguès A; Plésiat P; Jeannot K
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964794
[TBL] [Abstract][Full Text] [Related]
12. R
Kuang Q; He D; Sun H; Hu H; Li F; Li W; Hu G; Wu H; Yuan L
Antimicrob Agents Chemother; 2020 Oct; 64(11):. PubMed ID: 32868331
[TBL] [Abstract][Full Text] [Related]
13. PmrB mutations promote polymyxin resistance of Pseudomonas aeruginosa isolated from colistin-treated cystic fibrosis patients.
Moskowitz SM; Brannon MK; Dasgupta N; Pier M; Sgambati N; Miller AK; Selgrade SE; Miller SI; Denton M; Conway SP; Johansen HK; Høiby N
Antimicrob Agents Chemother; 2012 Feb; 56(2):1019-30. PubMed ID: 22106224
[TBL] [Abstract][Full Text] [Related]
14. Impact of two-component regulatory systems PhoP-PhoQ and PmrA-PmrB on colistin pharmacodynamics in Pseudomonas aeruginosa.
Ly NS; Yang J; Bulitta JB; Tsuji BT
Antimicrob Agents Chemother; 2012 Jun; 56(6):3453-6. PubMed ID: 22470116
[TBL] [Abstract][Full Text] [Related]
15. Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system.
Beceiro A; Llobet E; Aranda J; Bengoechea JA; Doumith M; Hornsey M; Dhanji H; Chart H; Bou G; Livermore DM; Woodford N
Antimicrob Agents Chemother; 2011 Jul; 55(7):3370-9. PubMed ID: 21576434
[TBL] [Abstract][Full Text] [Related]
16. Localized pmrB hypermutation drives the evolution of colistin heteroresistance.
Kapel N; Caballero JD; MacLean RC
Cell Rep; 2022 Jun; 39(10):110929. PubMed ID: 35675785
[TBL] [Abstract][Full Text] [Related]
17. Colistin resistance in Pseudomonas aeruginosa that is not linked to arnB.
Chung ES; Lee JY; Rhee JY; Ko KS
J Med Microbiol; 2017 Jun; 66(6):833-841. PubMed ID: 28621641
[TBL] [Abstract][Full Text] [Related]
18. Alterations in two-component regulatory systems of phoPQ and pmrAB are associated with polymyxin B resistance in clinical isolates of Pseudomonas aeruginosa.
Barrow K; Kwon DH
Antimicrob Agents Chemother; 2009 Dec; 53(12):5150-4. PubMed ID: 19752280
[TBL] [Abstract][Full Text] [Related]
19. Comparative evaluation of colistin broth disc elution (CBDE) and broth microdilution (BMD) in clinical isolates of Pseudomonas aeruginosa with special reference to heteroresistance.
Banerjee T; Adwityama A; Sharma S; Mishra K; Prusti P; Maitra U
Indian J Med Microbiol; 2024; 47():100494. PubMed ID: 37890411
[TBL] [Abstract][Full Text] [Related]
20. SPM-1-producing Pseudomonas aeruginosa ST277 clone recovered from microbiota of migratory birds.
Martins WMBS; Narciso AC; Cayô R; Santos SV; Fehlberg LCC; Ramos PL; da Cruz JB; Gales AC
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):221-227. PubMed ID: 29224710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
